Thompson Davis & Co., Inc. Dexcom Inc Transaction History

Thompson Davis & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $7,142 - $8,955	-55 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$23.35 - $36.72 $934 - $1,468	-40 Reduced 42.11%	55 $8,000
Q2 2018 Aug 03, 2018	BUY	$17.54 - $25.22 $1,666 - $2,395	95 New	95 $9,000
Q1 2018 May 02, 2018	SELL	$13.06 - $18.54 $31,174 - $44,254	-2,387 Closed	0 $0
Q4 2017 Feb 05, 2018	BUY	$11.12 - $15.38 $26,543 - $36,712	2,387	2,387 $137,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.9B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.